The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study.

Ann Surg 2016 Dec;264(6):1009-1015

*Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan†Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan‡Esophageal Surgery Division, National Cancer Center Hospital, Tokyo, Japan§Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan¶Department of Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan||Esophageal Surgery Division, National Cancer Center Hospital East, Kashiwa, Japan**Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan††Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan‡‡Department of Surgery, Niigata Cancer Center Hospital, Niigata, Japan§§Department of Surgery, Shizuoka General Hospital, Shizuoka, Japan¶¶Japan Clinical Oncology Group Data Center, National Cancer Center, Tokyo, Japan||||Department of Surgery, Keio University, School of Medicine, Tokyo, Japan.

Objective: To evaluate the sites and frequencies of overall and initial lymph node (LN) metastases (LNMs) of clinical T1N0 esophageal cancer.

Background: The sites and frequencies of initial LNMs and sentinel LNs (SLNs) of esophageal cancer remain unclear.

Methods: The Japan Clinical Oncology Group JCOG0502 trial was a 4-arm prospective study that compared esophagectomy with chemoradiotherapy for clinical T1N0 esophageal cancer in both randomized and patient-preference arms. The preoperative diagnostic accuracy was evaluated for patients assigned to the surgery arm. Patients who withdrew consent and who were not treated were excluded. All patients underwent esophagectomy with D2 or greater LN dissection. From the pathologic findings, sites and frequencies of LNMs and SLNs were assessed and the frequency of skip LNMs was calculated.

Results: In total, 211 patients underwent LNM and SLN analysis. Regarding N-factor accuracy, 57 (27.0%) of 211 clinical N0 cases had pathologic LNMs. The upper mediastinal and mediastinal/abdominal regions were frequent sites of LNMs in upper and lower thoracic cases, respectively. However, in middle thoracic cases, LNMs were observed in the neck, mediastinal, and abdominal regions, and pathologic SLN spread to all 3 fields. The frequency of skip LNMs was 36.7%.

Conclusions: A clinical diagnosis of T1N0 is not sufficiently accurate, and therefore, it is unacceptable to omit LN dissection or minimize the prophylactic radiation field. SLNs, which are not location restricted, should be surveyed in all 3 fields.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001557DOI Listing
December 2016
31 Reads

Publication Analysis

Top Keywords

sites frequencies
12
esophageal cancer
12
clinical t1n0
12
skip lnms
8
lnms upper
8
frequency skip
8
frequencies initial
8
thoracic cases
8
patients underwent
8
t1n0 esophageal
8
lnms
8
node metastases
8
initial lymph
8
lymph node
8
clinical
6
cases middle
4
assigned surgery
4
patients assigned
4
lower thoracic
4
analysis n-factor
4

Similar Publications